CDKN1A and breast carcinoma: To gain an understanding of the proteomic fluctuations occurring in breast cancer cells post p14ARF-p53-p21 expression, we employed stable isotope labeling of amino acids in cell culture (SILAC) and tandem mass spectrometry techniques (LC-MS/MS) [18].